Synthroid is made by chemically synthesizing levothyroxine sodium in a laboratory, then blending it with inactive ingredients and pressing the mixture into color-coded tablets. The process starts with a naturally occurring amino acid called L-tyrosine and ends with a tightly controlled tablet that must contain between 95% and 105% of its labeled potency throughout its entire shelf life.
The Starting Material: L-Tyrosine
Levothyroxine, the active ingredient in Synthroid, is a synthetic copy of the T4 hormone your thyroid gland produces. Manufacturing begins with L-tyrosine, a common amino acid found throughout nature. Chemists treat L-tyrosine with iodine chloride in acetic acid, then modify the molecule through a series of steps including acetylation and esterification. This creates a diiodotyrosine intermediate at roughly 75% yield.
From there, the molecule undergoes further chemical reactions to build out the full thyroid hormone structure, which features four iodine atoms attached to two connected ring-shaped structures. One of the final steps is iodination, which adds the remaining iodine atoms, followed by conversion into a sodium salt form. That last reaction is highly efficient, achieving about 95% yield. The result is levothyroxine sodium, a pure, lab-made compound that is chemically identical to what a healthy thyroid produces.
How It Differs From Desiccated Thyroid
Before synthetic levothyroxine existed, thyroid medication came from dried, ground-up pig thyroid glands, known as desiccated thyroid extract. These animal-derived products contain a mix of thyroid hormones along with many other biological compounds that have never been fully characterized for safety or effectiveness. Tablets made from the same manufacturing batch of animal glands may not deliver consistent hormone levels from one pill to the next.
Synthetic levothyroxine sidesteps these problems entirely. Because it’s built molecule by molecule in a controlled chemical process, every batch can be tested and verified to contain a precise amount of the active ingredient. The FDA has noted that unapproved animal-derived thyroid medications carry an increased risk of impurities tied to their biological source material.
Turning Powder Into Tablets
Levothyroxine is an extremely potent drug. A typical dose is measured in micrograms, meaning each tablet contains an almost invisibly small amount of active ingredient mixed into a much larger volume of inactive material. Getting such a tiny quantity distributed evenly across thousands of tablets is one of the core manufacturing challenges.
The solution is a technique called geometric dilution. Manufacturers first blend the levothyroxine sodium powder with a small portion of a filler (microcrystalline cellulose is commonly used). This creates a concentrated premix, or “triturate.” That triturate is then gradually blended with the remaining inactive ingredients in stages, each time roughly doubling the volume. This stepwise approach prevents the active ingredient from clumping in one spot and ensures every tablet gets a uniform dose.
Once the powder blend is homogeneous, it’s fed into a tablet press that compresses it into solid tablets using direct compression. This is a dry process, which matters because levothyroxine is sensitive to moisture and can degrade when exposed to it. Tablets are pressed to a minimum crushing strength of 3 kiloponds, firm enough to survive shipping and handling but designed to dissolve readily in your digestive tract. After compression, tablets are sealed into blister packs or bottles to protect them from humidity.
What’s Inside Besides Levothyroxine
The bulk of each Synthroid tablet is made up of six inactive ingredients: acacia (a natural gum used as a binder), confectioner’s sugar (which contains corn starch), lactose monohydrate, magnesium stearate, povidone, and talc. These serve as fillers, binders, and lubricants that give the tablet its size, hold it together, and help it flow smoothly through manufacturing equipment. Synthroid contains no ingredients derived from gluten-containing grains like wheat, barley, or rye.
Each tablet strength also contains specific color additives. The 50 mcg tablet is white with no added dye. The 25 mcg tablet uses a yellow dye, the 150 mcg uses a blue dye, and the 200 mcg uses a red dye. Synthroid comes in 12 different strengths ranging from 25 mcg to 300 mcg, and each one has a distinct color. This color-coding system exists so that patients and pharmacists can quickly identify the correct dose by sight, reducing the chance of a dispensing error with a medication where even small dosage differences matter.
Quality Control and Potency Standards
Levothyroxine has a narrow therapeutic window, meaning small changes in potency can produce noticeable effects on your thyroid levels. For this reason, the FDA requires all approved levothyroxine products to stay within a 95% to 105% potency specification for their entire labeled shelf life. This standard, formalized in 2007 after years of documented stability problems across the industry, is tighter than what many other medications require.
During manufacturing, dissolution testing confirms that each batch will release the drug properly once swallowed. Synthroid tablets are tested using a paddle apparatus spinning at 50 revolutions per minute in 500 milliliters of fluid, with samples drawn at 10, 20, 30, and 45 minutes. The tablet must release a specified percentage of its levothyroxine content within 45 minutes. Multiple lots of every tablet strength are tested this way before a batch reaches pharmacy shelves.
This combination of tight potency limits and standardized dissolution testing is what makes synthetic levothyroxine reliably consistent from refill to refill. It’s also why doctors and pharmacists often caution against switching between different levothyroxine brands or generics without retesting your thyroid levels: even within the allowed 95% to 105% range, a shift from the high end to the low end of that window can be enough for some people to feel a difference.